Millennium Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-30,000
Closed -$965K 4645
2019
Q1
$965K Buy
+30,000
New +$928K ﹤0.01% 2887

Millennium Management's XENT Position: Q2 2022 in Review

Millennium Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 510,536 shares — an estimated $14.3M sold.

Millennium Management first reported a position in XENT in Q3 2014 and held it in 25 quarters. The position peaked at $43.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Millennium Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Millennium Management sold 510,536 Intersect ENT, Inc shares in Q2 2022, an estimated $14.3M.
  • Millennium Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 25 quarters.
  • Millennium Management's Intersect ENT, Inc position peaked at $43.1M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.